Home  >  News
  US FDA approves Inspirion’s RoxyBond tablets for management of pain,   April 28, 2017
  US FDA accepts Santen Pharma's NDA for IVT sirolimus to trerat non-infectious uveitis of posterior segment,   April 27, 2017
  US FDA approves Sanofi & Regeneron's new once-monthly dosing option for Praluent injection,   April 27, 2017
  CPhI expert plea for reducing time for ANDA approvals,   April 27, 2017
  UL buys Texas-based medical device consultants, Emergo,   April 27, 2017
  US FDA issues warning letters to 14 companies for selling illegal cancer treatments,   April 27, 2017
  Sanofi's Thymoglobulin receives US FDA approval for prevention of acute kidney transplant rejection,   April 26, 2017
  Samsung Bioepis receives US FDA approval for Renflexis across all eligible indications,   April 26, 2017
  Fresenius Kabi to acquire biosimilars business of Akorn and Merck KGaA,   April 25, 2017
  MMT receives US FDA clearance for reusable fat collection and grafting system,   April 25, 2017
  Daiichi Sankyo’s DMD treatment drug, DS-5141 designated under SAKIGAKE Designation System,   April 25, 2017
  CHMP recommends approval of Bristol-Myers' bladder cancer drug Opdivo,   April 24, 2017
  NuVasive launches new spinal trauma portfolio,   April 22, 2017
  Japanese pharma companies forecast to have 17% growth in 2017,   April 21, 2017
  PSI, Pfizer collaborate to address hypertension in Vietnam & Myanmar,   April 21, 2017
  Eyevensys receives UK MHRA approval to advance its EyeCET platform into clinical development,   April 21, 2017
  Omnicell completes acquisition of Mississippi-based nPharmics,   April 20, 2017
  Japan Vaccine Co seeks Japanese approval for Shingrix for prevention of shingles,   April 20, 2017
  Rigel Pharma submits NDA to US FDA for fostamatinib in patients with chronic ITP,   April 20, 2017
  Roche’s Tecentriq receives US FDA accelerated approval to treat certain people with advanced bladder cancer,   April 20, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |